Dr. Daniel Perez-Zsolt (Barcelona, 1987) is a biochemist and biotechnologist (BSc at the Autonomous University of Barcelona, 2010) with a strong background in immunology, which he acquired during his MSc in Advanced Immunology at the University of Barcelona (2013). He has collaborated in research projects at the Clinical Biochemistry Laboratory (Veterinary Faculty, Autonomous University of Barcelona) and the Experimental Immunology Group (Hospital de la Santa Creu i de Sant Pau). In 2015 he joined IrsiCaixa as a pre-doctoral researcher, where he studied the interactions between enveloped viruses (HIV-1 and the emerging Ebola virus) and host myeloid antigen-presenting cells in the group of retrovirology and clinical studies led by Dr. Javier Martinez-Picado. After obtaining his PhD in Biochemistry, Molecular Biology and Biochemistry by the Autonomous University of Barcelona in 2020, he joined the newly created group of Emerging Pathogens PISTA led by Dr. Nuria Izquierdo Useros as a post-doctoral researcher. There, he aims at studying viral interaction with myeloid antigen-presenting cells in order to find new therapeutic strategies against SARS-CoV-2 infection.